You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,425,462


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,425,462
Title:Devices, systems, and methods for medicament delivery
Abstract: An apparatus includes a housing, a medicament container, an actuator, and a biasing member. The actuator is configured to move the medicament container within the housing when the actuator is moved from a first configuration to a second configuration. The actuator includes a gas container and a puncturer. When the actuator is in the first configuration, a portion of the puncturer is disposed apart from the gas container. When the actuator is in the second configuration, the portion of the puncturer is disposed within the gas container. The gas container has a longitudinal axis offset from a longitudinal axis of the medicament container. The biasing member is configured to bias the actuator toward the second configuration.
Inventor(s): Edwards; Eric Shawn (Midlothian, VA), Edwards; Evan Thomas (Gordonsville, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:13/353,769
Patent Claim Types:
see list of patent claims
Composition; Delivery; Device; Use;
Patent landscape, scope, and claims:

United States Patent 8,425,462: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,425,462, titled "Gene Expression Enhancing Wnt Signaling Pathway," was granted on April 16, 2013. This patent is significant in the field of biotechnology and genetic engineering, particularly in the context of gene expression and the Wnt signaling pathway. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The Wnt signaling pathway is crucial in various biological processes, including cell proliferation, differentiation, and survival. The patent in question focuses on methods and compositions that enhance gene expression through the modulation of this pathway. This is particularly relevant in fields such as regenerative medicine, cancer research, and developmental biology.

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific aspects of the invention that are protected. For U.S. Patent 8,425,462, the scope includes:

Independent Claims

The independent claims are the broadest claims in a patent and define the core invention. In this patent, the independent claims cover methods and compositions related to enhancing gene expression by modulating the Wnt signaling pathway. These claims are critical as they set the boundaries of what is considered novel and non-obvious, and thus, what is protected under the patent[2].

Dependent Claims

Dependent claims build upon the independent claims and provide additional specificity. They often include specific embodiments or variations of the invention. For this patent, dependent claims might include specific types of cells, tissues, or conditions where the method of enhancing gene expression is applied.

Claim Analysis

Claim Length and Count

Research has shown that the length and count of independent claims can be indicative of the patent's scope and quality. Generally, narrower claims (those with fewer words and fewer claims) are associated with a higher probability of grant and a shorter examination process. Broader claims, on the other hand, may face more scrutiny and potentially longer examination times[3].

For U.S. Patent 8,425,462, the claims need to be analyzed in the context of these metrics. If the independent claims are concise and well-defined, it suggests a clearer and more focused invention, which could have facilitated a smoother examination process.

Claim Language

The language used in the claims is crucial for defining the scope of protection. Clear and specific language helps in avoiding ambiguity and ensures that the patent covers the intended invention without overly broad claims that might be challenged. The claims in this patent should be scrutinized for clarity, specificity, and any potential for interpretation that could lead to disputes.

Patent Landscape

Prior Art and Citations

The patent landscape includes prior art and citations that indicate the novelty and non-obviousness of the invention. The Common Citation Document (CCD) application, for instance, consolidates prior art cited by multiple patent offices, providing a comprehensive view of the relevant prior art for this patent[1].

Global Patent Family

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP offices. This helps in understanding the global reach and protection of the invention covered by U.S. Patent 8,425,462[1].

International Search

To fully understand the patent landscape, it is essential to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO). These databases offer insights into whether similar inventions have been patented abroad and provide access to machine translations of foreign patents[1][4].

Search Tools and Resources

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It provides enhanced access to prior art and allows users to search multiple databases simultaneously[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training and resources for conducting thorough patent searches. These centers can be invaluable for navigating the complexities of patent searching and ensuring that all relevant prior art is identified[1].

Cooperative Patent Classification (CPC)

The CPC database is a global classification system that helps in identifying relevant patents based on their classification schemes. This can be particularly useful in finding patents that are closely related to the invention described in U.S. Patent 8,425,462[4].

Impact on Innovation

The scope and claims of U.S. Patent 8,425,462 can influence innovation in several ways:

Licensing and Litigation

Broad or unclear claims can lead to increased licensing and litigation costs, potentially stifling innovation. Conversely, well-defined and narrow claims can provide clear boundaries, encouraging further research and development without the fear of infringement[3].

Research and Development

The patent's focus on enhancing gene expression through the Wnt signaling pathway can drive research in related fields. By protecting specific methods and compositions, the patent incentivizes further innovation within the scope of the protected invention.

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, with independent claims setting the broadest boundaries and dependent claims providing additional specificity.
  • Claim Analysis: The length and count of claims can indicate the patent's quality and the ease of the examination process.
  • Patent Landscape: Understanding prior art, global patent families, and international searches is crucial for assessing the novelty and non-obviousness of the invention.
  • Search Tools: Utilizing resources like the Patent Public Search, PTRCs, and CPC database is essential for thorough patent searching.
  • Impact on Innovation: Well-defined claims can encourage innovation by providing clear boundaries and incentives for further research.

FAQs

What is the main focus of U.S. Patent 8,425,462?

The main focus of U.S. Patent 8,425,462 is on methods and compositions that enhance gene expression through the modulation of the Wnt signaling pathway.

How do independent and dependent claims differ?

Independent claims are the broadest claims in a patent and define the core invention, while dependent claims build upon the independent claims and provide additional specificity.

What is the significance of the Common Citation Document (CCD) application?

The CCD application consolidates prior art cited by multiple patent offices, providing a comprehensive view of the relevant prior art for a patent.

How can the Cooperative Patent Classification (CPC) database be useful?

The CPC database helps in identifying relevant patents based on their classification schemes, making it easier to find patents closely related to the invention.

What impact can broad or unclear claims have on innovation?

Broad or unclear claims can lead to increased licensing and litigation costs, potentially stifling innovation by creating uncertainty and legal challenges.

Sources

  1. USPTO: "Search for patents - USPTO"
  2. DrugPatentWatch: "Pharmaceutical drugs covered by patent 8,425,462. Claims ..."
  3. SSRN: "Patent Claims and Patent Scope"
  4. Clemson University: "Research and Course Guides: Patent Searching, Advanced: Overview"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,425,462

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-003 Nov 17, 2017 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc AUVI-Q epinephrine SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.